Search Results - Hardev S. Pandha

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    The PERK Inhibitor GSK2606414 Enhances Reovirus Infection in Head and Neck Squamous Cell Carcinoma via an ATF4-Dependent Mechanism by Martin McLaughlin, Malin Pedersen, Victoria Roulstone, Katharina F. Bergerhoff, Henry G. Smith, Harriet Whittock, Joan N. Kyula, Magnus T. Dillon, Hardev S. Pandha, Richard Vile, Alan A. Melcher, Kevin J. Harrington

    Published in Molecular Therapy: Oncolytics (2020-03-01)
    Get full text
    Article


  2. 2

    The oncolytic adenovirus Ad-TD-nsIL12 in primary or progressive pediatric IDH wild-type diffuse intrinsic pontine glioma results of two phase I clinical trials by Xiao Qian, Weihai Ning, Jingjing Yang, Louisa Chard Dunmall, Hardev S. Pandha, Guanjie Shang, Yuduo Guo, Dongxu Zhang, Yanming Qu, Haoran Wang, Chunyu Gu, Mingshan Zhang, Yaohe Wang, Shengdian Wang, Hongwei Zhang

    Published in Nature Communications (2025-07-01)
    Get full text
    Article


  3. 3

    Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in pat... by Christy Ralph, Sumati Gupta, Matthew Zibelman, Brendan D Curti, Kevin J Harrington, Steven J O'Day, Andrew G Hill, David C Campbell, Gavin M Wright, David E Gerber, Jonathan E Rosenberg, Jaime R Merchan, Charles M Rudin, Hardev S Pandha, Wallace L Akerley, Daphne Day, Timothy D Clay, Ross R Jennens, Yixin Ren, Emmett V Schmidt, Lisa Guttman

    Published in Journal for ImmunoTherapy of Cancer (2023-01-01)
    Get full text
    Article


Search Tools: